Calvert Investment Management’s Novo Nordisk NVO Stock Holding History

Calvert Investment Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-27,964	Closed	-$501K	–	416
2016 Q4	$501K	Sell	27,964 -174	-0.6%	-$3.15K	0.02%	536
2016 Q3	$585K	Sell	28,138 -2,004	-7%	-$49.7K	0.02%	500
2016 Q2	$811K	Hold	30,142	–	–	0.03%	392
2016 Q1	$817K	Hold	30,142	–	–	0.04%	362
2015 Q4	$875K	Sell	30,142 -5,294	-15%	-$147K	0.04%	317
2015 Q3	$961K	Hold	35,436	–	–	0.05%	229
2015 Q2	$970K	Buy	35,436 +17,162	+94%	+$482K	0.04%	244
2015 Q1	$488K	Hold	18,274	–	–	0.03%	364
2014 Q4	$387K	Buy	18,274 +464	+3%	+$10.4K	0.03%	393
2014 Q3	$424K	Sell	17,810 -16,622	-48%	-$383K	0.03%	356
2014 Q2	$795K	Buy	34,432 +842	+3%	+$18.6K	0.05%	188
2014 Q1	$767K	Sell	33,590 -4,250	-11%	-$90.5K	0.05%	186
2013 Q4	$699K	Hold	37,840	–	–	0.05%	200
2013 Q3	$640K	Hold	37,840	–	–	0.08%	196
2013 Q2	$586K	Buy	+37,840	New	+$630K	0.08%	190

Other funds holding NVO

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Calvert Investment Management's NVO Position: Q1 2017 in Review

Calvert Investment Management sold out of Novo Nordisk (NVO) in Q1 2017, closing a stake of 27,964 shares — an estimated $501K sold.

Calvert Investment Management first reported a position in NVO in Q2 2013 and held it in 15 quarters. The position peaked at $970K in Q2 2015. 463 funds tracked by Wall St. Rank hold NVO as of Q1 2017.

Calvert Investment Management reported no remaining Novo Nordisk position as of Q1 2017 after selling out during the quarter.
Calvert Investment Management sold 27,964 Novo Nordisk shares in Q1 2017, an estimated $501K.
Calvert Investment Management first reported a position in Novo Nordisk in Q2 2013 and held it in 15 quarters.
Calvert Investment Management's Novo Nordisk position peaked at $970K in Q2 2015.
463 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2017.

Based on Calvert Investment Management's 13F filing for Q1 2017.